Latanoprost Completed Phase 3 Trials for Glaucoma / Ocular Hypertension Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00800267A Study of Glaucoma or Ocular Hypertension in Patients Within the United States
NCT02105272Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension